Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MK-7162 |
| Synonyms | |
| Therapy Description |
MK-7162 inhibits indoleamine 2,3-dioxygenase 1 (IDO1) resulting in decreased production of kynurenine from tryptophan, which potentially leads to increased anti-tumor immune response (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MK-7162 | MK7162|MK 7162 | IDO1 Inhibitor 13 | MK-7162 inhibits indoleamine 2,3-dioxygenase 1 (IDO1) resulting in decreased production of kynurenine from tryptophan, which potentially leads to increased anti-tumor immune response (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|